ACS BrightEdge Poised to Help Improve 1.5 Million Lives By Investing in Cancer-Focused Therapies and Technologies

Posted on by

American Cancer Society’s Impact Venture Fund Announces Annual Results and New Framework that Measures Investments’ Impact on Mission to End Cancer BOSTON, Aug. 16, 2023 /PRNewswire/ — BrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.